Department of Neurobiology, University of Alabama at Birmingham,
Birmingham, Alabama
Neuronal nicotinic acetylcholine receptor (nAChR) desensitization is
hypothesized to be a trigger for long-term changes in receptor number
and function observed after chronic administration of nicotine at
levels similar to those found in persons who use tobacco.
Factors that regulate desensitization could potentially influence the
outcome of long-lasting exposure to nicotine. The roles of
Ca2+ and protein kinase C (PKC) on desensitization of
4
2 nAChRs expressed in Xenopus laevis oocytes were
investigated. Nicotine-induced (300 nM; 30 min) desensitization of
4
2 receptors in the presence of Ca2+ developed
in a biphasic manner with fast and slow exponential time constants of
f = 1.4 min (65% relative amplitude) and
s = 17 min, respectively. Recovery from desensitization
was reasonably well described by a single exponential with
rec = 43 min. Recovery was largely eliminated after
replacement of external Ca2+ with Ba2+ and
slowed by calphostin C (
rec = 48 min), an inhibitor of
PKC. Conversely, the rate of recovery was enhanced by
phorbol-12-myristate-13-acetate (
rec = 14 min), a PKC
activator, or by cyclosporin A (with
rec = 8 min), a
phosphatase inhibitor.
4
2 receptors containing a mutant
4
subunit that lacks a consensus PKC phosphorylation site exhibited
little recovery from desensitization. Based on a two-desensitized-state cyclical model, it is proposed that after prolonged nicotine treatment,
4
2 nAChRs accumulate in a "deep" desensitized state, from
which recovery is very slow. We suggest that PKC-dependent
phosphorylation of
4 subunits changes the rates governing the
transitions from "deep" to "shallow" desensitized conformations
and effectively increases the overall rate of recovery from
desensitization. Long-lasting dephosphorylation may underlie the
"permanent" inactivation of
4
2 receptors observed after
chronic nicotine treatment.
 |
Introduction |
The
family of neurotransmitter-gated ion channels is responsible for fast
synaptic transmission in the peripheral and central nervous systems
(CNS) (Barnard et al., 1987
; Unwin, 1989
; Betz, 1990
). Functional
regulation of these receptors by second-messenger systems has often
been examined with respect to their involvement in neuronal plasticity
(Swope et al., 1992
; Smart, 1997
). How receptor modulation contributes
to possible dysfunction of receptors in disease states is less well
understood. It is possible that various intracellular mechanisms
required to regulate receptors under normal circumstances confer
long-lasting changes during abnormal conditions. Such receptor
regulation could underlie the "functional inactivation" of neuronal
nicotinic acetylcholine receptors (nAChRs) that occurs during and after
chronic exposure to nicotine (Lukas, 1991
; Peng et al., 1994
).
Neuronal nAChRs are amenable to a variety of physiologically relevant
forms of regulation. The number and/or function of receptors can be
increased through both cAMP-dependent and -independent mechanisms
(Margiotta et al., 1987
; Gurantz et al., 1993
), by protein kinase C
(PKC) (Downing and Role, 1987
), by the neurotransmitters vasoactive
intestinal peptide (Gurantz et al., 1994
; Cuevas and Adams, 1996
) and
Substance P (Role, 1984
), by changes in the extracellular concentration
of Ca2+ (Mulle et al., 1992b
; Vernino et al.,
1992
; Galzi et al., 1996
) and through interactions with the
cytoskeleton (Bencherif and Lukas, 1993
). In addition, the permeation
of Ca2+ through nAChR channels (Vernino et al.,
1992
) could activate intracellular cascades or other ion channels
(Mulle et al., 1992a
) and potentially induce changes in the
phosphorylation states of specific nAChR subunits (Vijayaraghavan et
al., 1990
; Nakayama et al., 1993
; Moss et al., 1996
). The long-term
functional consequences of such post-translational modifications remain
largely unexplored.
Because of nAChR subunit diversity (McGehee and Role, 1995
; Colquhoun
and Patrick, 1997
), their biochemical regulation may occur in a
subtype-specific manner. Although it is unclear which subtypes of
nAChRs predominate in CNS function, receptors containing
4 and
2
subunits contribute to a majority of the high-affinity nicotine binding
sites in the brain (Whiting and Lindstrom, 1988
; Flores et al., 1992
).
Furthermore, nicotine at levels related to tobacco use (Benowitz et
al., 1989
) both activates and desensitizes
4
2 nAChRs (Hsu et al.,
1995
; Fenster et al., 1997
); desensitization may initiate the
up-regulation of nAChR number that occurs during chronic nicotine
exposure (Wonnacott, 1990
; Schwartz and Kellar, 1985
).
Therefore, factors that regulate
4
2 nAChR function, especially those that modulate desensitization, may contribute to the long-term effects of nicotine on nAChR number and function. In this study, we
investigate second-messenger modulation of
4
2 nAChRs expressed in
Xenopus laevis oocytes. We show that the predominant role of Ca2+ and PKC is to regulate the rate of recovery
from desensitization.
 |
Experimental Procedures |
Expression of Functional nAChRs in X. laevis
Oocytes.
Detailed procedures for preparation of oocytes have been
described elsewhere (Quick and Lester, 1994
). Briefly, oocytes were defolliculated and maintained at 18°C in incubation medium containing ND96 (96 mM NaCl, 2 mM KCl, 1 mM MgCl2, 1.8 mM
CaCl2, and 5 mM HEPES, pH 7.4), 50 mg/ml
gentamicin, and 5% horse serum. Subunit cRNAs were synthesized in
vitro (machine message; Ambion, Austin, TX) from linearized plasmid
templates of rat cDNA clones. A mutant
4 subunit
(
4S336A) was created in which a consensus PKC
phosphorylation site (serine 336) was mutated to alanine (pALTER 1;
Promega, Madison, WI). The mutation was verified by sequencing. Oocytes
were injected with between 5 and 25 ng/subunit/oocyte;
and
subunits were injected in 1:1 ratios.
Electrophysiological Recording.
Whole cell currents were
measured at room temperature (20-25°C), 24 to 96 h after RNA
injection, with a Geneclamp 500 amplifier (Axon Instruments, Foster
City, CA) in a standard two-microelectrode, voltage-clamp
configuration. Electrodes were filled with 3 M KCl and had resistances
of 0.5 to 2 M
. Oocytes were clamped between
40 and
65 mV and
superfused continuously in media containing 1.8 mM
Ca2+ (control condition). In some experiments,
1.8 mM Ba2+ was substituted for
Ca2+. In some of the early experiments, membrane-
permeable drugs were applied by extracellular incubation. In the
majority of experiments, drugs (25 nl) were injected into the oocytes
10 to 30 min before experimentation, so as to avoid direct
extracellular effects of protein kinase activators/inhibitors on nAChR
channels (see Reuhl et al., 1992
). The approximate final concentrations
were: phorbol-12-myristate-13-acetate (PMA), 200 nM to 2 µM;
cyclosporin A, 500 nM to 1 µM; and calphostin C, 200 nM. Control
incubations or injections were performed with vehicle solutions:
0.125% dimethyl sulfoxide for calphostin C and PMA treatments.
Agonist-containing solutions were gravity-fed via a six-way manual
valve (Rainin Instruments, Woburn, MA) to the oocyte in the recording
chamber. Solution exchange considerations are discussed in Fenster et
al. (1997)
. All salts and drugs were obtained from Sigma (St. Louis,
MO). All currents were recorded on a chart recorder and on an
80486-based computer with AxoScope software (Axon Instruments) after
50- to 100-Hz low-pass filtering at a digitization frequency of 200 Hz.
For slowly desensitizing responses, peak currents were assessed on-line
from the digital readout of the amplifier.
Criteria for Data Selection.
For accurate voltage-clamp, and
to limit the activation of the endogenous
Ca2+-activated Cl
current
in oocytes, nicotine-induced currents greater than 3 µA were not
included in the data analysis; initial current amplitudes less than 50 nA were also excluded. Additionally, responses were at least 2-fold
greater than the holding current, and the holding current at a given
membrane potential was less than 100 nA. These criteria applied to all
nAChR currents activated at the EC50
concentration. Various desensitization parameters were estimated as
described previously (Fenster et al., 1997
). For the majority of
experiments, desensitization was studied using the methods of Katz and
Thesleff (1957)
and Feltz and Trautmann (1982)
. Briefly, the fraction
of activatable receptors before, during, and after a 30-min exposure to
300 nM nicotine was assessed from the amplitude of repetitively applied
test pulses (
5 s; 10-20 µM nicotine; interpulse interval, 5 min).
The respective time courses of desensitization onset and recovery were
estimated from exponential fits to the test pulse amplitude
during and after the 300 nM nicotine application. Fits were sometimes
constrained so that steady-state desensitization could not be less than
zero. For means of comparison across different conditions, the
magnitude of desensitization was calculated as the ratio
(Icon Ifinal)/Icon,
where Icon is the control test pulse amplitude and Ifinal is its amplitude
at the end of the 30-min nicotine application. In a few experiments,
desensitization onset and magnitude were determined from the response
to a 2- to 3-min application of 10 µM nicotine. For statistical
comparison of mean data, weighted-means Student's t
tests (for unpaired comparisons) and paired Student's t
tests (for paired comparisons) were performed. Comparisons of
exponential fits were by nonlinear regression analysis using SPSS
software (SPSS for Windows, Rel. 8.0.0. 1997; SPSS, Inc., Chicago,
IL). All data are expressed as the mean ± S.E.M. Kinetic
models of receptor desensitization were constructed using ScOP
(Simulation Resources Inc., Berrien Springs, MI).
 |
Results |
Ca2+ Regulates Recovery from
Desensitization.
It has been shown previously that desensitization
of
4
2 receptors induced by 3-min applications of 10 µM nicotine
occurs in a biexponential manner, with similar time constants in the presence or absence of Ca2+ (Fenster et al.,
1997
). However, recovery from desensitization showed a marked
dependence on the presence of extracellular Ca2+
(Fenster et al., 1997
). To further investigate the role of
Ca2+ on desensitization of
4
2 nAChRs,
experiments were performed after extracellular
Ca2+ was replaced by Ba2+
(Fig. 1).

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 1.
Recovery from desensitization is reduced in the
presence of Ba2+. The time courses of desensitization and
recovery were assessed from the inhibition of responses to a
repetitively applied (5-min intervals) brief (5-10 s) test pulse of
nicotine (10 µM) during incubations with 300 nM nicotine in the
presence of extracellular Ca2+ (A) or Ba2+ (B).
Time course plots of the test pulse amplitudes during 30 min
applications of nicotine (left) and example responses from these
experiments (right) are shown. Data are normalized to control nicotine
responses before nicotine application. The solid lines show double
exponential fits to the onset of desensitization, and the fast
( f) and slow ( s) time constants are
indicated. Recovery from desensitization in the presence of
Ca2+ was fit to both a single exponential (solid line) and
a double exponential with a fast recovery time constant constrained to
2.5 min (dashed line). In the latter fit, the fast component
represented 13% recovery and the slow recovery time constant was 54 min. Recovery from desensitization in the presence of Ba2+
was fit to a double exponential. The fast time constant represented
17% recovery. The slow time constant could not be defined. in A
(left) indicate the stability of the test pulse amplitude in the
absence of continuous exposure to nicotine. The effects of a 10 min
application of 300 nM nicotine on the rates of recovery from
desensitization (thick lines) are shown for both Ca2+ (C;
n = 4) and Ba2+ (D;
n = 3). Recovery was well described by a single
exponential component in Ca2+ but not in Ba2+.
The fitted exponentials for onset and recovery for the 30-min
applications are shown superimposed for comparison (thin lines).
|
|
After obtaining at least three stable test responses to nicotine
(10-20 µM; 2-10 s) applied at 5-min intervals, 300 nM nicotine was
continuously superfused for a period of 30 min. Test pulse amplitudes
were measured and plotted with respect to time before, during, and
after the prolonged exposure to nicotine. In the presence of
Ca2+ (Fig. 1A), exponential fits to the peak
responses showed that the onset of desensitization was biexponential
with fast (
f = 1.4 min) and slow
(
s = 17 min) time constants (n = 18). Mean recovery from desensitization was well described by a
single exponential function (
rec = 43 min).
The fractional desensitization at the end of the 30-min exposure to
nicotine was 0.79. Although all cells demonstrated recovery from
desensitization, there was some variability, particularly between
different batches of oocytes (e.g., compare recovery under control
conditions in Figs. 2 and 3). Single exponential fits to the
recovery phase from individual cells in Ca2+
produced values of
rec that ranged from 16.5 to 97.8 min (mean ± S.E.M.; 42.7 ± 6.8 min;
n = 14). Variability of this nature may be expected if
recovery from desensitization is regulated by intracellular biochemical
processes (see below). To reduce variability, we have, wherever
possible, compared oocytes from the same batch. To assess the role of
Ca2+ on the desensitization process, these
results were compared with those from experiments in which
Ba2+ had been substituted for extracellular
Ca2+. During exposure to 300 nM nicotine, the
onset and magnitude of desensitization were largely unaffected by
Ba2+. Ba2+ induced a
slowing of the second component of desensitization onset
(P < .05; Fig. 1B). However, apart from a small (17%)
rapid phase (
rec = 2.5 min), there was little
recovery of
4
2 nAChRs from desensitization in the presence of
Ba2+. These data are consistent with the
suggestion that Ca2+ may in part facilitate
recovery from desensitization via a
Ba2+-insensitive process. Moreover, the data in
Ba2+ indicate that recovery from desensitization
may occur in a biphasic manner. In control experiments (+ Ca2+), the fast component of recovery could have
been missed because of its relatively small amplitude; a constrained
double exponential fit (with the fast
rec set
to 2.5 min) demonstrated that the fast component would account for 13%
of the recovery in the presence of Ca2+ (Fig. 1A,
dashed line).

View larger version (27K):
[in this window]
[in a new window]
|
Fig. 2.
PKC activity regulates the rate of recovery from
desensitization. The time courses of desensitization and recovery
during a 30-min incubation with 300 nM nicotine in 4 2 expressing
oocytes injected with PMA (A) or calphostin C (B). In each case, these
oocytes were compared with control oocytes
(uninjected/vehicle-injected) from the same oocyte batch. Time-course
plots of the test pulse amplitudes (left) and example responses (right)
are shown. Data are normalized to control nicotine responses before
nicotine application. The solid lines show double exponential fits to
the onset of desensitization with fast ( f) and slow
( s) time constants for A: control, 1.2 (63%) and 9 min
(n = 4); PMA, 2.4 (59%) and 90 min
(n = 7); and for B: control, 2.3 (64%) and 65 min
(n = 4); calphostin C, 1.8 (82%) and 22 min
(n = 4). In all cases, recovery from
desensitization was well described by a single exponential and the time
constant is indicated.
|
|

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 3.
Phosphatase inhibition increases the rate of recovery
from desensitization. The time courses of desensitization and recovery
during a 30-min incubation with 300 nM nicotine in 4 2-expressing
oocytes injected with cyclosporin A. These oocytes were compared with
control oocytes (uninjected/vehicle-injected) from the same oocyte
batch. Time-course plots of the test pulse amplitudes (A) and example
responses (B) are shown. Data are normalized to control nicotine
responses before nicotine application. The solid lines show double
exponential fits to the onset of desensitization with fast
( f) and slow ( s) time constants for
control of 2.7 (88%) and 22 min (n = 3) and for
cyclosporin A of 2.2 (76%) and 11 min (n = 3). The
time courses of recovery from desensitization were in both cases well
described by a single exponential and the time constant is indicated.
|
|
In addition, based on the comparison of recovery from desensitization
for the two divalents, we would argue that Ba2+
selectively eliminates the slow component of recovery. However, because
the fast component of recovery from desensitization is small (
20%)
after 30-min nicotine treatment, it is difficult to accurately assess
the effects of Ba2+ on this phase of recovery. To
address this problem, the time allowed for development of
desensitization was limited by reducing the application of 300 nM
nicotine to 10 min (Fig. 1, C and D). The rationale is based upon
receptor models that have two sequential desensitized states associated
with fast and slow transitions, respectively (see below; Feltz and
Trautmann, 1982
; Boyd, 1987
). Because access to the two states
is dependent on the time of exposure to agonist, shorter applications
will result in fewer receptors in the slowly formed state than in the
faster reached state. When agonist is removed, a greater percentage of
receptors will recover with a faster time course. As predicted under
these conditions, recovery from desensitization became faster in
Ca2+ (Fig. 1C). More importantly, the relative
fraction of the fast phase of recovery was increased in the presence of
Ba2+, whereas the slow phase was again
essentially absent (Fig. 1D). Although we cannot accurately resolve the
fast component of recovery from desensitization in
Ca2+, this phase seems unaffected by
Ba2+, because the first 5 min of recovery in
Ba2+ and Ca2+ are
essentially the same (compare Fig. 1, C and D). Thus, the effects of
Ba2+ on desensitization are largely restricted to
the slow phase of recovery.
PKC Regulates
4
2 Receptor Desensitization.
Several
mechanisms could account for the enhancement of recovery from
desensitization by Ca2+. Two possibilities are
that, in addition to enhancing activation (Mulle et al., 1992b
; Vernino
et al., 1992
; Galzi et al., 1996
), Ca2+ binding
to an external site on
4
2 nAChRs also alters desensitization or
that Ca2+ entry into the oocyte regulates the
desensitization recovery process. To address the possible intracellular
consequences of Ca2+, we assessed the effects of
inhibition and activation of Ca2+-dependent
protein kinases and phosphatases. For both muscle-type nAChRs (Hardwick
and Parsons, 1996
) and neuronal nAChRs in chromaffin cells (Khiroug et
al., 1998
), recovery from desensitization is dependent upon the state
of phosphorylation and is controlled via a
Ca2+-dependent phosphatase and PKC. Similar
regulation of
4
2 nAChRs is possible, because
4
2 receptors
are potential targets for modification by PKC (Goldman et al., 1987
;
Deneris et al., 1988
). Injection of
4
2-expressing oocytes with
PMA had two major effects on desensitization (Fig. 2A): compared with
untreated oocytes from the same batch of cells, in the presence of
extracellular Ca2+, there was an increase in the
rate of recovery from desensitization (
rec = 14 min; n = 6; P < .05) and there was
a reduction in the magnitude of desensitization (0.71;
n = 10; P < .05). In another batch of
oocytes, inhibition of PKC by calphostin C had the opposite effect
(Fig. 2B). There was an increase in the magnitude of desensitization (0.92; n = 3; P < .05) and the rate of
recovery from desensitization was slowed (
rec = 48 min; n = 3; P < .05). These data
imply that PKC activity modulates
4
2 receptor desensitization:
activation of PKC enhances recovery from desensitization and its
inhibition reduces recovery.
Phosphatase Inhibition Enhances Rate of Recovery from
Desensitization.
The PMA and calphostin C data are consistent with
the hypothesis that factors that promote phosphorylation enhance the
rate of recovery from desensitization. An alternative method of
promoting phosphorylation is to suppress dephosphorylation through
phosphatase inhibition. Because the function of many ligand-gated
channels is affected by the Ca2+-dependent
phosphatase calcineurin (Yakel, 1997
), the effects of the phosphatase
inhibitor cyclosporin A on recovery from desensitization of
4
2
nAChRs were examined. Compared with a control group of oocytes from the
same batch, the action of cyclosporin A was almost identical with the
effects of activation of PMA (Fig. 3); that is, a dramatic increase in
the rate of recovery from desensitization (
rec = 8 min; n = 3; P < .05) and a slight
decrease in the magnitude of desensitization (0.62; n = 3; P > .05). These data support the suggestion that
both the extent of
4
2 receptor desensitization and the rate of
recovery are determined by the balance of phosphatase and kinase activity.
Elimination of a PKC Phosphorylation Site in
4 Subunit Inhibits
Recovery from Desensitization.
The data above imply that
modulation of recovery from desensitization of
4
2-containing
nAChRs may involve the Ca2+-dependent activation
of PKC. One pathway for generating such specificity would be direct
phosphorylation of the
4 or
2 subunit by PKC. In addition to two
protein kinase A (PKA) sites, the
4 nAChR contains five consensus
sites for PKC phosphorylation on the cytoplasmic loop between
transmembrane regions 3 and 4, and the
2 subunit contains one PKC
site in this region (Goldman et al., 1987
; Deneris et al.,
1988
). One of these sites on the
4 subunit, serine 336, is analogous
to a site (serine 333) on the muscle
subunit that is a likely site
of PKC-dependent phosphorylation (Huganir et al., 1984
). To test the
hypothesis that this site is important for recovery from
desensitization, a mutant
4 receptor subunit was created in which
serine 336 was replaced with alanine. This subunit, denoted
4S336A, was expressed in oocytes along with a
wild-type
2 subunit. These mutant receptors formed ion channels that
were activated and desensitized by nicotine (10 µM) in a manner
similar to wild-type
4
2 nAChRs (Fig.
4). Dose-response relationships in the
presence of Ca2+ yielded an
EC50 value of 13 µM, also similar to wild-type
4
2 receptors (Fenster et al., 1997
). The onset of desensitization (nicotine 10 µM; 2 min) could be described by a single (1/6 cells) or
a biexponential decay (5/6 cells), with fast
[
f = 6.9 ± 1.6 s (24%)] and slow
(
s = 135 ± 20 s) time constants;
these data are not significantly different from wild-type receptors
[
f = 5.1 ± 0.4 s (24%)];
s = 109 ± 22 s). The magnitude of
desensitization in
4S336A
2 nAChRs,
estimated at the end of a 2-min nicotine application, was less than in
wild-type
4
2 receptors: 0.46 ± 0.02 (n = 6) compared with 0.59 ± 0.02 (n = 7;
P < .05).

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 4.
Properties of mutant 4S336A 2
receptors. A, concentration-response relationship for activation of
mutant 4S336A 2 receptors. The solid curve is a
logistic fit to the data, with a Hill slope of 1.0. B, comparison of
currents induced by 2-min applications of nicotine in wild-type
4 2- (left) and 4S336A 2- (right) expressing
oocytes.
|
|
Recovery from desensitization for wild-type
4
2 receptors was
compared with recovery for
4S336A
2
receptors. Assuming that the mutation at this site on the
4 subunit
interferes with the ability of kinases and phosphatases to modulate
recovery from desensitization, then the mutant receptor should show
slowed recovery from desensitization. Fig.
5 shows that although the mutation did
not markedly affect the onset of desensitization, as expected
from the brief pulses (Fig. 4B), there was a profound loss of recovery
from desensitization compared with wild-type receptors expressed in the
same batch of oocytes. These results are qualitatively similar to those
found with Ba2+. That is, after a small (29%)
fast phase of recovery [
rec (fast) = 7.2 min], the slow phase was almost absent, at least during the time
course (>30 min) of the experiment (Fig. 5). Thus, the mutant receptor
reproduces one of the effects of PKC inhibition, a slowing of the
recovery process, but does not mimic the increase in the extent of
desensitization observed with calphostin C (Fig. 2B). These data imply
that other factors may be important for regulation of
4
2 receptor
desensitization.

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 5.
Recovery from desensitization is reduced in mutant
4S336A 2 receptors. A, the time courses of
desensitization and recovery were assessed during a 30-min incubation
with 300 nM nicotine in wild-type 4 2 (filled symbols) or mutant
4S336A 2 (open symbols) receptors. Time-course plots
of the test pulse amplitudes (left) and example responses (right) are
shown. All oocytes are from the same batch. Data are normalized to
control nicotine responses before nicotine application. The solid lines
show double exponential fits to the onset of desensitization and the
fast and slow time constants for wild-type 4 2 and mutant
4S336A 2 receptors. Recovery from desensitization of
wild-type 4 2 receptors has been fit to a single exponential with
its time constant shown. Recovery from desensitization of mutant
4S336A 2 receptors was best fit with the sum of two
exponentials. B, Initial stability of peak amplitudes of test pulses.
Brief pulses of nicotine (10 µM) were applied at 5- and 10-min
intervals to oocytes expressing either wild-type 4 2 (filled
symbols; n = 10) or mutant
4S336A 2 (open symbols; n = 11).
Time-course plots of the test pulse amplitudes (left) and example
responses (right) are shown.
|
|
If the action of PMA involves direct PKC-mediated phosphorylation at
serine 336 [rather than being independent of PKC (Nishizaki and
Sumikawa, 1995
)], recovery from desensitization in
4S336A
2 receptors should not be enhanced by
PMA treatment. In the presence of both PMA and cyclosporin A, the
overall extent of recovery from desensitization of mutant nAChRs was
enhanced, as judged from the appearance of a slow phase of
desensitization [
rec (slow) = 63 min; data
not shown] that was absent in untreated mutant receptors (Fig. 5). The
fast phase of recovery from desensitization was unaffected by this
treatment [
rec (fast) = 9.0 min]. Because cyclosporin A and PMA did not enhance recovery from desensitization of
mutant nAChRs [
rec (slow) = 63 min] to the
same extent as wild-type receptors (
rec = 30 min; data not shown), these results are consistent with the idea that
elimination of serine 336 prevents some of the effects of PKC
activation on the slow phase of recovery.
Models of
4
2 Receptor Desensitization.
The most
convenient method for understanding how phosphorylation could regulate
4
2 nAChR function is to examine the consequences of changing
transition rates between the various distinct states in a Markov model.
As discussed by others, cyclical schemes that incorporate desensitized
conformations with high affinities for agonist can describe reasonably
well both the onset and recovery of desensitization (Katz
and Thesleff, 1957
). The biexponential time course kinetics observed in
the present study are most readily explained by a model with two
desensitized states (Feltz and Trautmann, 1982
; Boyd, 1987
):

|
(Scheme 1)
|
|
For simplicity, we assume that one molecule of agonist
A can produce channel opening by binding to the R
state, and that the closed bound state AR is in rapid
equilibrium with the open conformation. Binding of agonist to the
desensitized states, D1 and
D2 will cause a loss of receptors in
the R states and consequent desensitization. As others have
argued previously (Feltz and Trautmann, 1982
), we suggest that the
rates of formation of AD1 and
AD2 underlie the fast and slow onset
components of desensitization, respectively. Conversely, after removal
of agonist, both of these states will unbind agonist relatively rapidly
(see below), and the fast and slow recovery phases will be limited by
the rates of the transitions from D1
R and D2
D1, respectively.
K0 = k
0/k+0 is the apparent affinity for the activatable state and
K1 = k
1/k+1 and K2 = k
2/k+2
are the apparent affinities for the two desensitized conformations.
L1 and
L2 are the allosteric constants describing the ratios of desensitized and activatable receptors, L1 = D1/R = l+1/l
1 and
L2 = D2/D1 = l+2/l
2. We
have shown that the apparent affinity
(K0 ) of nicotine for rat
4
2
nAChRs expressed in oocytes is 10 µM (Fenster et al., 1997
), which
means that the fraction of activatable receptors AR occupied
by 300 nM nicotine is very low (
0.03). Therefore, because
60% of receptors are "instantaneously" (<2 min) desensitized (Table 1), the fast component of
desensitization must proceed via the transition R
D1. At very low agonist
concentrations, and ignoring the "deep" desensitized state for now,
the fraction of activatable receptors in this model is given by (see
also Feltz and Trautmann, 1982
):
|
(1)
|
At 300 nM nicotine,
R/Rmax
0.4 (Fig. 1). If
K1 = 100 nM (a high enough affinity
for interaction with nanomolar concentrations of nicotine), then
L1
1. The individual rates
l+1 and
l
1 can be calculated based on the
observation that the equilibration of R and
D1 is fast [i.e.,
f
1 min (Table 1)]:
|
(2)
|
In this case l+1 = l
1 = 0.5 min
1. In this model, the rate constants
d+1 and
d
1 will set the time course of the
fast phase of desensitization at high agonist concentrations (Dilger
and Liu, 1992
; see Fig. 7F). The time constant
f for this process (
5 s; see Fig. 4)
is related to the rate constants by:
|
(3)
|
At 10 µM nicotine, f, the fraction of receptors in
AR, is 0.5. In addition, because the ratio
d+1/d
1
is constrained by microscopic reversibility:
|
(4)
|
and therefore
d+1/d
1 = 100. Substitution of this ratio back into eq. 3 gives
d+1 = 24 min
1 and
d
1 = 0.24 min
1. After the initial fast phase of
desensitization, most receptors will be in
AD1 and the slow component of
desensitization will reflect the transition
AD1
AD2.
Because only 10 to 20% recovery occurs with a fast time course, the
forward rate constant (and hence the
d+2/d
2
ratio) must be large enough to drive most receptors into the slowly
recovering AD2 state by the end of a 30-min
exposure to nicotine. With a
d+2/d
2
ratio of 20 and a slow desensitization onset time constant,
s = 15 min,
d+2 = 0.064 min
1, and d
2 = 0.0032 min
1. Provided that equilibrium
[3H]nicotine binding reflects the equilibration
with the high-affinity desensitized state
D2, then a
K2 of 1 nM is consistent with reported values (Wonnacott, 1987
). Under these conditions, the second allosteric constant L2
(l+2/l
2)
is also constrained by microscopic reversibility to 0.2 (see eq. 4).
The individual allosteric rates that determine the slow rate of
recovery from desensitization can be calculated from eq. 2 assuming a
slow recovery time constant,
rec = 30 min.
Assuming again that [3H]nicotine is associated
with D2,
k
2 should reflect the time course of
agonist dissociation. The rate constant for this process has been
estimated previously from rat brain membranes as
0.5 min
1 at room temperature (Marks and Collins,
1982
). For an affinity constant of 1 nM, the association rate would
then be 500 min
1. The final values of all the
rate constants are shown in Table 1.
View this table:
[in this window]
[in a new window]
|
TABLE 1
Model rate constants
Except where changes from control rate constants are shown, all rates
remained unaltered.
|
|
Simulations with Scheme 1 show that pulse durations of 5 to 10 s
could be readily sustained at 5-min intervals after a small loss of
response caused by some equilibration of agonist with the deep
desensitized state AD2. This type of
use-dependent initial response stabilization (Fig.
6A) was often observed in the oocyte experiments (see Fig. 5B). A 30-min exposure of the model to 300 nM
nicotine produced a biphasic onset and recovery from desensitization with appropriate time constants (Fig. 6B). After 20-min applications of
various concentrations of nicotine (Fig. 6C, arrow), a
pseudo-steady-state desensitization dose-response curve was constructed
(Fig. 6D). The estimated half-maximally effective concentration
(IC50) of nicotine for inducing desensitization
was 61 nM, similar to values obtained experimentally (Fenster et al.,
1997
).

View larger version (35K):
[in this window]
[in a new window]
|
Fig. 6.
Simulation of 4 2 receptor desensitization. A,
initial stability of test pulse amplitude. Simulated responses to
10-s applications of nicotine (10 µM) at 10-min (left) or 5-min
(right) intervals. The percentage loss of response is shown in each
case after 20 min of stimulation. B, simulated desensitization
experiment using 2-s pulses of nicotine (10 µM) applied at 5-min
intervals before, during, and after exposure to 300 nM nicotine for 30 min. Desensitization onset and recovery are described by double
exponentials (dashed lines) with time constants (and relative
amplitudes) indicated. Test pulse responses were allowed to stabilize
before simulated exposure of the model to 300 nM nicotine. C, time
course of the change in the fraction of activatable receptors during
exposure to various concentrations of nicotine. D, plot of the
available receptor fraction after 20-min nicotine exposure (arrow in C)
with respect to nicotine concentration. The sold line is a logistic fit
to the simulated data.
|
|
The major effect of biochemical manipulation in the present work is
consistent with an altered rate of recovery from
desensitization. Both Ba2+ substitution (Fig. 2)
and the mutant receptor (Fig. 5) produced an increase in the time
constant associated with the slow phase of recovery, with little
apparent effect on the relative amplitudes of the fast and slow
components. The time course of the slow phase of recovery is determined
by both rate constants that govern the transition
D2
D1. However, because the rate out of
desensitization l
2 is 5-fold faster
than l+2, it will dominate the overall
rate of recovery (see eq. 2). Indeed, with the present model,
manipulation of this rate constant was the only method of mimicking the
data we observed with the mutant channel. A 3-fold reduction in
l
2 produced a slowing of the slow
recovery phase with little or no effect on any other process (Fig.
7A; Table 1). Thus, we would argue that
the effects of the
4 mutation and the actions of
Ba2+ can be largely explained by slowing the
transition D2
D1. Because these are cyclical
schemes, alteration of one rate will destroy microscopic reversibility.
To overcome this problem, the rate constant
d
2 for the transition
AD2
AD1 was changed by the same amount. In
addition to making thermodynamic sense, changing both rates that govern
return from the "deep" desensitized state seems appropriate,
because changing the phosphorylation state of the receptor may be
expected to have similar effects whether or not agonist is bound (Boyd,
1987
; Eilers et al., 1997
). A final consequence of altering
l
2 is to affect the allosteric constant L2, which will result in a
shift in the relative fractions of receptors in the unbound states; a
3-fold reduction in this rate constant effectively increases the number
of desensitized receptors D2 and
consequently reduces the number of activatable receptors R
at rest. Thus, an additional effect of the mutation/dephosphorylation is to slightly reduce the maximal response that can be generated (see
Fig. 7F).

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 7.
The effects of rate-constant changes on the time
course of desensitization. A, simulated test pulse (nicotine, 2 s;
10 µM) amplitudes during and after a 30-min simulated exposure to 300 nM nicotine. The rate of recovery from desensitization is slowed by a
3-fold reduction in l 2
(d 2 was reduced by a similar amount to
maintain microscopic reversibility). A 3-fold increase in
l 2 (and d 2)
increased the rate of recovery (B), whereas a 3-fold decrease in
d+2 (and l+2)
increased the fraction of receptors that recovered with a fast time
constant and reduced the magnitude of desensitization (C). Opposite
rate changes mimic the effects of PKC activation (D) and inhibition (E)
(see Fig. 2). D, a 2-fold increase in l 2
balanced by a 2-fold decrease in d+2
enhanced the rate of recovery and decreased the magnitude of
desensitization. E, a 2-fold decrease in
l 2 balanced by a 2-fold increase in
d+2 reduced the rate of recovery and
increased the magnitude of desensitization. Open symbols indicate the
test pulse amplitudes and solid lines are exponential fits. In A-E, the
control behavior is shown with dashed lines. F, simulated currents in
response to brief pulses of nicotine (3 min; 10 µM). From left to
right, traces show responses with control rate constants and adjusted
rate constants as in part E (calphostin C) and A (mutant). The
fast desensitization time constant and its relative percentage are the
same for each of the three simulations.
|
|
The effects of the phosphorylation state on desensitization of
wild-type nAChRs are more complex than the relatively simple changes
associated with the mutant channel. In addition to effects on the slow
phase of recovery, there are changes in the magnitude of
desensitization (Table 2). For example,
PMA enhances the rate of recovery from desensitization, an effect that
can be mimicked by an increase in the rate constant
l
2, thereby speeding up the
transition D2
D1 (Fig. 7B). However, this
manipulation alone does not predict the PMA- and cyclosporin A-induced
changes in the magnitude of desensitization (Fig. 2A). Slowing the rate constant d+2 that controls the onset
of desensitization AD1
AD2 (and
l+2;
D1
D2) does decrease the extent of
desensitization; however, with this rate change, recovery from
desensitization is enhanced by increasing the relative contribution of
the fast phase of recovery and not by altering the rate of recovery
(Fig. 7C). These results suggest that the effects of PKC perturbation may be explained by alterations in both the forward and
reverse rate constants that define the transitions between the
"shallow" D1 and "deep"
D2 desensitized states. Attempts to
mimic both PKC activation and inhibition are shown in Fig. 7, D and E,
respectively. In the case of PMA, the rate of recovery
(D2
D1) is enhanced by a 2-fold increase
in l
2 and the magnitude of
desensitization (AD1
AD2 ) is reduced by a 2-fold decrease
in d+2 (note that these two changes
are consistent with detailed balancing). The opposite changes in these
rate constants produce a desensitization time course that is consistent
with inhibition of PKC. Because an increase in the rate of
desensitization onset drives more receptors into the "deep"
desensitized state by the end of the 30-min nicotine application, the
fast component of recovery is largely absent compared with the mutant
receptor. This behavior agrees well with the experimental data (Fig. 2B
and Fig. 5A).
 |
Discussion |
Protein phosphorylation is essential for G protein-coupled
receptor desensitization (Freedman and Lefkowitz, 1996
). In the case of
ligand-gated channels, phosphorylation plays a modulatory rather than a
necessary role in receptor desensitization (Huganir and Greengard,
1990
). Examination of the functional properties of
4
2 nAChRs
expressed in X laevis oocytes has revealed that recovery
from desensitization is specifically amenable to certain forms of
biochemical regulation. It is proposed that Ca2+
and factors that promote phosphorylation, possibly directly of the
4
subunit, enhance the overall rate of recovery from desensitization.
Desensitization of
4
2 Receptors.
Since the initial
studies of Katz and Thesleff (1957)
, much effort has been invested in
defining the process of desensitization in both molecular and
biophysical terms. Current models of desensitization for most
ligand-gated ion channels are based around cyclical schemes with two
distinct desensitized states (Sakmann et al., 1980
; Feltz and
Trautmann, 1982
; Boyd, 1987
). Consistent with these studies, we have
shown that the time courses of desensitization onset and recovery
display biexponential kinetics. It is possible that this type of
behavior can be explained by the existence of two separate channels:
one with fast desensitization properties and one with slow
desensitization properties (for example, see Maconochie and Knight,
1992
). However, after short applications of nicotine (10 min),
the fast component dominates both the onset of and recovery from
desensitization, whereas after 30-min exposure to nicotine, the slow
component (
80%) predominates during recovery. This implies that the
fast and slow phases are not independent. These data are most readily
explained by the existence of a single receptor type with complex
desensitization characteristics (Feltz and Trautmann, 1982
). After
brief desensitization, most receptors have time only to reach a fast
desensitized state from which recovery is also fast. During prolonged
desensitization, more receptors are converted to a slowly reached
desensitized state, from which recovery is also slow.
Our analysis of desensitization measures the fraction of receptors that
remain in the activatable R state during exposure to
agonist. Desensitization is effectively the reduction in the relative
abundance of this receptor conformation. In the model (see Scheme 1),
all the properties of desensitization (e.g., time course,
concentration-dependence) are constrained by the rate constants that
determine the equilibrium between the various states. Because the fast
phase of
4
2 receptor desensitization occurs rapidly (<2 min) and
contributes > 60% of desensitization onset at 300 nM nicotine,
50% of channels must exist (in the absence of agonist) in a
relatively high-affinity, "shallow," desensitized state
D1. Agonist rapidly combines with this
state to form AD1 and receptors are
rapidly recruited from R to
D1 to restore equilibrium. After
removal of agonist, the AD1 state is
short-lived (i.e., "shallow") because the large rate constants
necessary to permit the rapid onset of desensitization onset
R
D1 also determine its
rate of recovery. Thus recovery from desensitization will be fast with
brief agonist applications, and slowed after longer periods of agonist,
as more receptors have time to accumulate in the longer-lived,
"deep" desensitized AD2
conformation (Feltz and Trautmann, 1982
; Boyd, 1987
). We estimate
that
80% of
4
2 channels can get to this state after a
30-min exposure to 300 nM nicotine. Recovery from this state is slow
and is the rate-limiting process of restoring receptor function after
prolonged agonist applications.
Regulation of Recovery from Desensitization.
The involvement
of phosphorylation in recovery from desensitization of neuronal nAChRs
has recently been demonstrated (Khiroug et al., 1998
). Boyd (1987)
,
however, first suggested that a biochemical process may
specifically regulate the slow phase of neuronal nAChR desensitization. In the present study, we have confirmed Boyd's idea.
We find that Ca2+ and PKC are involved in the
regulation of the slow phase of recovery from desensitization. For
example, with Ba2+ substitution,
4
2
receptors displayed a marked reduction in the slow rate of recovery,
with no other differences from control conditions. Mechanistically
speaking, this can only be explained by a reduction in the rate
constant that allows escape from the "deep" desensitized state
D2
D1. The slower rate of recovery from
desensitization in Ba2+-containing media implies
that Ca2+ may be important for normal
4
2
receptor function. It seems unlikely that the action of
Ca2+ results from direct binding to an
extracellular site on the receptor (Mulle et al., 1992b
; Vernino et
al., 1992
; Galzi et al., 1996
) because Ba2+,
which can replace Ca2+ in its ability to increase
nAChR responses (Mulle et al., 1992b
), does not substitute for
Ca2+ in the enhancement of recovery from
desensitization. Therefore, Ca2+ influx, perhaps
in part via the nAChR channel itself (Mulle et al., 1992a
; Vernino et
al., 1992
), may be important for its effects on recovery.
Ca2+ could be acting directly on the
intracellular face of the receptor (Miledi, 1980
; Cachelin and
Colquhoun, 1989
) or through activation of various
Ca2+-dependent kinases and phosphatases, as
suggested for nAChRs in chromaffin cells (Khiroug et al., 1998
). We
have shown that activation and inhibition of PKC enhances and
attenuates the slow rate of recovery from desensitization of
4
2
nAChRs, respectively, consistent with the idea that factors that
promote phosphorylation facilitate recovery from the "deep"
desensitized state. Because recovery from desensitization can be
enhanced both by phosphatase inhibition and by PKC activation, it is
suggested that the rate of recovery from desensitization will be
governed by the relative balance of kinase and phosphatase activity.
Because the effects of Ba2+ in wild-type
4
2
receptors are almost identical with the behavior of the mutant
4S336A
2 nAChR, we would argue that the
dominant role of Ca2+ under the present
conditions is to facilitate recovery from desensitization, possibly
through activation of PKC.
4 Subunits are Potential Substrates for PKC.
Direct
phosphorylation of
4 nAChR subunits by PKA (Nakayama et al., 1993
)
is enhanced by chronic treatment with nicotine (Hsu et al., 1997
).
Although various muscle nAChR subunits act as PKC substrates (Huganir
and Greengard, 1990
), no equivalent direct PKC-mediated phosphorylation
of neuronal nAChRs has been demonstrated. As predicted from our results
with inhibition and activation of PKC, the PKC-site mutant
4S336A
2 nAChR exhibited a decrease in the
slow time constant of recovery from desensitization, which suggests
that PKC-dependent phosphorylation at this site may be important for
recovery of function. However, the effects of inhibition of PKC were
not restricted entirely to the recovery from desensitization; there was
also an increase in the magnitude of desensitization. Based on our
model, we suggest that this may be explained by an increase in the rate
constant governing entry into the "deep" desensitized state. In
other reports, the onsets of desensitization of muscle-type nAChRs
(Huganir et al., 1986
; Hoffman et al., 1994
) and nAChRs in
sympathetic ganglia (Downing and Role, 1987
) are enhanced by PKA and
PKC activation, respectively. In the case of chromaffin cells, any
action of PKC on desensitization onset and/or steady-state response may
have been missed (Khiroug et al., 1998
), because the high
concentrations of agonist used would rapidly drive the majority of
receptors into the "shallow" desensitized state and the transition
to the "deep" state would become largely silent (see Fig. 7F).
Furthermore, because the rate of recovery from desensitization in the
mutant receptor could be partially enhanced by a combination of
cyclosporin A and PMA, it is likely that the effects of phosphorylation
on desensitization are not limited to one site on
4 subunits. Indeed the
4 subunit alone contains five potential PKC sites (Goldman et
al., 1987
) and can be heavily phosphorylated in oocytes in vivo
(Viseshakul et al., 1998
). Our results do not necessarily indicate that
PKC directly phosphorylates this site; rather, the mutation could be
affecting the interaction of the
4 subunit with some intermediate
protein or it could confer a conformational change in the subunit that
itself alters the rate of recovery from desensitization. In this
respect, we did observe a slight decrease in the magnitude of
desensitization in mutant nAChRs that was not predicted.
Overall, although the kinetic model and its rate constants are not
likely to be unique solutions for
4
2 receptor desensitization, together with the experimental data, these results imply that there is
more than one site of action of PKC on
4
2 nAChRs, and that the
effects of phosphorylation and dephosphorylation are probably confined
to the transitions between the "deep" and "shallow" desensitized states. There is no direct evidence that phosphorylation can regulate native
4
2 nAChRs in neurons; however, the
desensitization properties of nAChRs both in chromaffin cells (Khiroug
et al., 1998
) and at the neuromuscular junction (Hardwick and Parsons, 1996
) are modulated by phosphorylation, as are those for
N-methyl-D-aspartate (Tong et al.,
1995
) and
-aminobutyric acidA (Martina et al., 1996
) receptors. These data imply that phosphorylation-dependent regulation of desensitization may be a general mechanism for
ligand-gated ion channels (Huganir and Greengard, 1990
).
Implications for Nicotine Addiction.
Prolonged exposure to
levels of nicotine related to use of tobacco up-regulates the number of
high-affinity (
4
2) nicotine binding sites in the CNS (Marks et
al., 1983
; Schwartz and Kellar, 1985
; Flores et al., 1992
) and in
heterologous expression systems (Peng et al., 1994
; Gopalakrishnan et
al., 1996
). In contrast to the increase in receptor number, the
functional responsiveness of nAChRs is markedly reduced (Lukas, 1991
;
Marks et al., 1993
; Peng et al., 1994
). It has been suggested that
reduced function is a consequence of nAChRs entering a "permanently
inactive" state (Lukas, 1991
; Peng et al., 1994
), probably via
agonist-induced desensitized conformations (Boyd, 1987
). Previously we
have demonstrated that
4
2 nAChRs have an intrinsically slow rate
of recovery from desensitization after a 30-to 60-min treatment with
levels of nicotine related to use of tobacco (Fenster et al., 1997
). We suggest here that desensitization of nAChRs induced by prolonged exposure to nicotine may result in a reduced Ca2+
influx, thereby promoting the dephosphorylated state of
4
2 receptors. Recovery from the "deep" desensitized conformation would
be markedly slowed, and receptors would become "trapped" in a
chronically desensitized/deactivated state (Lukas, 1991
; Peng et al.,
1994
). Indeed, it has been reported that prolonged treatment with PKC
inhibitors will also drive
4
2 nAChRs to a functionally inactive
conformation (Eilers et al., 1997
). Chronic PMA treatment, which
down-regulates PKC activity (Favaron et al., 1990
), promotes an
increase in the number of
4
2 receptors (Gopalakrishnan et al.,
1997
), consistent with the suggestion that the dephosphorylated state
of the receptor could either directly or indirectly serve as a signal
for preventing receptor turnover (Peng et al., 1994
).
This research was supported by United States Public Health
Service Grants DA11940 and NS31669 (R.A.J.L.) and the W. M. Keck Foundation 931360. M.L.B. is sponsored in part by the Medical Scientist
Training Program. J.C.P. is sponsored by the Neuroscience Training Program.
CNS, central nervous system;
nAChR, nicotinic
acetylcholine receptor;
PKC, protein kinase C;
PKA, protein kinase A;
PMA, phorbol-12-myristate-13-acetate.